Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics

News   Nov 24, 2016

 
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
 
 
 

RELATED ARTICLES

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

Flow Chemistry Process Development: Johnson Matthey and Snapdragon Chemistry Announce Partnership

News

Johnson Matthey and Snapdragon Chemistry Inc. are pleased to announce that they have entered in to a collaborative agreement to provide integrated continuous manufacturing services – from development to full-scale GMP manufacturing.

READ MORE

£2.2M Collaboration to Fuel Drug Developments for HIV

News

A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further £2.2M ($3M) to develop sophisticated new medicines for HIV.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE